Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$561M |
| 2 |
Citizens Financial Group
CFG
|
+$465M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$462M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$439M |
| 5 |
WEC Energy
WEC
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$1.33B |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1B |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$968M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$740M |
| 5 |
Wells Fargo
WFC
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.24% |
| 2 | Financials | 14.23% |
| 3 | Technology | 13.63% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPXX
3726
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $810K | ﹤0.01% |
361,591
+20,409
| +6% | +$46.3K |
|
3727
Aldeyra Therapeutics
ALDX
$93.5M
| $802K | ﹤0.01% |
+103,470
| New | +$892K |
|
|
MSON
3728
DELISTED
Misonix Inc
MSON
| $802K | ﹤0.01% |
84,411
+1,000
| +1% | +$12.1K |
|
|
MBII
3729
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $800K | ﹤0.01% |
404,017
+7,663
| +2% | +$21.7K |
|
|
BYLK
3730
DELISTED
BAYLAKE CORP
BYLK
| $798K | ﹤0.01% |
63,117
+1,000
| +2% | +$12.5K |
|
3731
Ohio Valley Banc Corp
OVBC
$202M
| $794K | ﹤0.01% |
35,086
+125
| +0.4% | +$2.83K |
|
|
PERF
3732
DELISTED
Perfumania Holdings, Inc.
PERF
| $794K | ﹤0.01% |
139,864
+1,418
| +1% | +$7.8K |
|
|
GVP
3733
DELISTED
GSE Systems, Inc.
GVP
| $792K | ﹤0.01% |
51,068
-750
| -1% | -$11.5K |
|
3734
AudioCodes
AUDC
$256M
| $789K | ﹤0.01% |
244,199
| – | – |
|
|
NVO
3735
Novo Nordisk
NVO
$196B
| $789K | ﹤0.01% |
28,800
-70,400
| -71% | -$1.98M |
|
|
SAUC
3736
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $787K | ﹤0.01% |
211,550
+9,000
| +4% | +$36K |
|
|
ENVI
3737
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $783K | ﹤0.01% |
412,366
+9,542
| +2% | +$17.1K |
|
|
OSHC
3738
DELISTED
Ocean Shore Holding Co.
OSHC
| $773K | ﹤0.01% |
52,111
+1,000
| +2% | +$15.1K |
|
3739
RCM Technologies
RCMT
$204M
| $768K | ﹤0.01% |
135,606
+3,266
| +2% | +$19.4K |
|
3740
WIX.com
WIX
$2.79B
| $768K | ﹤0.01% |
32,513
+9,652
| +42% | +$220K |
|
|
GV
3741
DELISTED
Goldfield Corporation
GV
| $768K | ﹤0.01% |
462,801
+8,600
| +2% | +$14.1K |
|
|
FGNX
3742
FG Nexus Inc
FGNX
$44.2M
| $767K | ﹤0.01% |
753
+32
| +4% | +$30.8K |
|
|
ONVI
3743
DELISTED
Onvia, Inc.
ONVI
| $761K | ﹤0.01% |
178,550
+78
| +0% | +$351 |
|
|
TRNX
3744
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
| $760K | ﹤0.01% |
42
+5
| +14% | +$76.8K |
|
3745
Colony Bankcorp
CBAN
$470M
| $751K | ﹤0.01% |
83,469
| – | – |
|
|
CTHR
3746
DELISTED
Charles & Colvard Ltd
CTHR
| $747K | ﹤0.01% |
49,513
+194
| +0.4% | +$2.78K |
|
3747
Friedman Industries
FRD
$255M
| $735K | ﹤0.01% |
117,551
+763
| +0.7% | +$4.96K |
|
|
TBCH
3748
Turtle Beach Corp
TBCH
$276M
| $734K | ﹤0.01% |
80,445
+1,052
| +1% | +$9.13K |
|
|
ALXA
3749
DELISTED
Alexza Pharmaceuticals Inc
ALXA
| $733K | ﹤0.01% |
672,611
+3,616
| +0.5% | +$5.43K |
|
3750
Harrow
HROW
$1.48B
| $731K | ﹤0.01% |
89,966
+2,296
| +3% | +$18.7K |
|
Similar funds
Vanguard Group's Q2 2015 Portfolio in Review
As of Q2 2015, Vanguard Group held 4,259 positions worth $1.48T, up 0.33% from $1.47T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 4%. Vanguard Group opened 105 new positions and exited 67, leaving the 4,259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Vanguard Group's largest Q2 2015 buy was Uniti Group: 7,979,038 shares worth $197M.
- Vanguard Group added most to AbbVie in Q2 2015, an estimated $561M increase.
- Vanguard Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $968M.
- Vanguard Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $1.33B.
- Vanguard Group's ten largest holdings make up 13% of its $1.48T portfolio in Q2 2015.
- Vanguard Group opened 105 new positions and closed 67 in Q2 2015.
- Vanguard Group's portfolio value rose 0.33% quarter-over-quarter to $1.48T.
Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.